does semaglutide damage liver Can you take Wegovy with fatty disease? Once-Weekly Subcutaneous Semaglutide Improves Fatty

Niya Mansuri, weight loss expert at myBMI Wegovy 0.25 mg, FlexTouch solution for injection in pre-filled pen (2026) EMC [accessed 9 March 2026] Ozempic 0.25 mg solution for injection in pre-filled pen (2025) EMC [accessed 9 March 2026] Non-alcoholic fatty liver disease (NAFLD) (2025) NHS [accessed 9 March 2026] Sleep apnoea (2022) NHS [accessed 9 March 2026] Physical activity guidelines for adults aged 19 to 64 (2024) NHS [accessed 9 March 2026] Semaglutide for managing overweight and obesity (2023) NICE [accessed 9 March 2026] Tirzepatide for managing overweight and obesity (2025) NICE [accessed 9 March 2026] Once-weekly semaglutide 72 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial (2025) National Library of Medicine [accessed 9 March 2026] Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension (2022) National Library of Medicine [accessed 9 March 2026] Wegovy (2025) Novo Nordisk [accessed 9 March 2026] Its natural to have questions, and were here to keep things straightforward so you can stay focused on your journey

References Lopez-Otin, C., Blasco, M

Despite their potential benefits, the risk of psychiatric adverse effects requires cautious administration

SMD, standardized mean difference

L-carnitine facilitates the transport of fatty acids to the mitochondria, where they are converted into energy

Epidemiological data have shown that serum uric acid levels are associated with cardiac hypertrophy in patients with underlying risk factors, such as renal transplant, non-valvular atrial fibrillation, metabolic syndrome and menopause (Caliskan et al., 2011